AI Detection System, Critical Limb Ischemia Device Gain FDA 'Breakthrough' Status

Two companies disclosed Breakthrough Device designations from US FDA on Jan. 29, one for an artificial intelligence tool for detecting intracranial hemorrhage, and the other for a system to treat critical limb ischemia.